Generic Substitution
96.8% of your pharmacy spend goes to branded drugs when 71% have a generic available. Substitution is clinically safe 99.8% of the time.
The Biggest Silent Leak in Pharmacy
Here is what it looks like: pharmacies systematically dispense branded drugs when a generic alternative is available. This is not an occasional error — it is a structural misalignment of incentives. Pharmacies earn higher margins on branded products, so the generic stays on the shelf.
The numbers are revealing: 96.8% of pharmaceutical spend goes to branded drugs. 71% of these branded products have a generic available, but less than 5% is dispensed as generic. And substitution is clinically safe 99.8% of the time.
This is not fraud in the traditional sense. It is an incentive misalignment where pharmacies are filling the prescription correctly — they dispense exactly what was prescribed. But the prescriber could have indicated the generic with the same clinical outcome and significantly lower cost.
What We Detect
Inspector AI identifies every branded dispense where a generic alternative is available and substitution would be clinically safe. This is not about recommending risky substitutions — 99.8% of identified substitutions are clinically safe.
Our analysis covers the complete catalog of dispensed medications, comparing each branded product against available generic alternatives. The substitution intelligence accounts for clinical safety, generic availability, and price differential.
It is important to clarify that we do not reveal the lookup logic or product matching criteria we use. What matters is that every opportunity identified has been validated for clinical safety.
Why It Matters
Generic substitution represents the single largest savings opportunity: $16 median per dispense, with an annual projection of $4.53M per 50,000 subscribers. It is by far the highest financial impact category.
Unlike other patterns, generic substitution does not require accusing anyone of fraud. It is simply an optimization opportunity where everyone wins: the insurer saves, the patient receives the same treatment, and the system becomes more sustainable.
96.8%
Branded spend
71%
Brands with generic
<5%
Dispensed as generic
99.8%
Clinically safe
$16
Median per dispense
$4.53M/yr
Annual projection per 50K
Discover Your Generic Substitution Opportunity
We'll show you how much you could save with generic substitution in your network. Free analysis of your data.
Request Free Analysis